MetLife Investment Management, LLC
Position in DNLI — Denali Therapeutics Inc.
CIK 1529735
Whippany, NJ
Position in DNLI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,202,172
+$713,059 QoQ
Shares Held
85,621
+10.4% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#93
of 290 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MetLife Investment Management, LLC holds $430,307,229 across 249 Biotechnology names. DNLI ranks #41 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
402,605 | $31,511,893 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
90,543 | $30,312,890 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
58,072 | $28,846,104 | |
| 4 | FTRE |
Fortrea Holdings Inc.
|
1,362,169 | $23,701,740 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
89,662 | $21,946,567 | |
| 6 | IMNM |
Immunome Inc.
|
859,076 | $18,203,820 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,880 | $14,266,595 | |
| 8 | CYTK |
Cytokinetics Inc
|
140,046 | $11,930,518 |
All Filings in DNLI
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,202,172 | 85,621 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,489,113 | 77,558 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,240,957 | 75,164 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $1,148,169 | 79,075 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,106,259 | 79,075 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,016,430 | 74,765 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,549,899 | 76,050 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,091,825 | 71,810 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,667,428 | 71,810 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,277,657 | 62,264 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,336,185 | 62,264 | Shares | Defined | 2024-04-22 | |
| 2023-09-30 | $1,284,506 | 62,264 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $1,837,410 | 62,264 | Shares | Defined | 2024-04-29 | |
| 2023-03-31 | $1,313,902 | 57,027 | Shares | Defined | 2024-05-09 | |
| 2022-12-31 | $1,585,920 | 57,027 | Shares | Defined | 2024-05-10 | |
| 2022-09-30 | $1,608,984 | 52,427 | Shares | Defined | 2024-05-10 | |
| 2022-06-30 | $1,483,036 | 50,392 | Shares | Defined | 2024-05-10 | |
| 2022-03-31 | $1,621,110 | 50,392 | Shares | Defined | 2024-05-10 | |
| 2021-12-31 | $1,444,549 | 32,389 | Shares | Defined | 2024-05-17 | |
| 2021-09-30 | $1,634,025 | 32,389 | Shares | Defined | 2024-05-17 | |
| 2021-06-30 | $2,540,593 | 32,389 | Shares | Defined | 2024-05-17 | |
| 2021-03-31 | $1,414,024 | 24,764 | Shares | Defined | 2024-05-17 | |
| 2020-12-31 | $2,074,232 | 24,764 | Shares | Defined | 2024-05-24 | |
| 2020-09-30 | $1,007,252 | 28,112 | Shares | Defined | 2024-05-24 | |
| 2020-06-30 | $679,748 | 28,112 | Shares | Defined | 2024-05-24 | |
| 2020-03-31 | $397,301 | 22,690 | Shares | Defined | 2023-07-12 | |
| No filing history on record for this holder in this stock. | ||||||